LY-255582

出自Local Chinese Wikipedia
跳至導覽 跳至搜尋
LY-255582
File:LY-255,582.svg
首選IUPAC名
3-{(3R,4R)-1-[(3S)-3-Cyclohexyl-3-hydroxypropyl]-3,4-dimethylpiperidin-4-yl}phenol
識別
CAS號 119193-09-8
PubChem 9906198
ChemSpider 8081850
SMILES
 
  • C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)CC[C@@H](C3CCCCC3)O
InChI
 
  • 1/C22H35NO2/c1-17-16-23(13-11-21(25)18-7-4-3-5-8-18)14-12-22(17,2)19-9-6-10-20(24)15-19/h6,9-10,15,17-18,21,24-25H,3-5,7-8,11-14,16H2,1-2H3/t17-,21-,22+/m0/s1
InChIKey LVVHEFJXPXAUDD-BULFRSBZBD
性質
化學式 C22H35NO2
摩爾質量 345.52 g·mol−1
若非註明,所有數據均出自標準狀態(25 ℃,100 kPa)下。

LY-255582是一種含氮有機化合物,化學式為C22H35NO2,屬於苯基哌啶類化合物,可作為阿片類受體的非選擇性受體拮抗劑[1],在肥胖實驗大鼠中具有減肥作用[2]

參考文獻[編輯]

  1. Dhaher R, et al. Effects of naltrexone and LY255582 on ethanol maintenance, seeking, and relapse responding by alcohol-preferring (P) rats.. Alcohol (Fayetteville, N.Y.). Feb 2012, 46 (1): 17–27. PMC 4581853可免費查閱. PMID 21962974. doi:10.1016/j.alcohol.2011.08.011. 
  2. Shaw WN, et al. The effect of the opioid antagonist LY255582 on body weight of the obese Zucker rat.. International Journal of Obesity. Jun 1991, 15 (6): 387–95. PMID 1653188.